ClinicalTrials.Veeva

Menu

Remote Alcohol Monitoring to Facilitate Abstinence Reinforcement: Feasibility

M

Mikhail Koffarnus

Status and phase

Completed
Phase 2
Phase 1

Conditions

Alcohol Use Disorder

Treatments

Behavioral: Contingency management: Contingent incentives
Behavioral: Contingency management: Noncontingent incentives

Study type

Interventional

Funder types

Other

Identifiers

NCT03507075
R21AA022727

Details and patient eligibility

About

Directly reinforcing abstinence from alcohol with monetary incentives is an effective treatment for alcohol dependence, but barriers in obtaining frequent, verified biochemical measures of abstinence limit the dissemination of this treatment approach. The goal of this feasibility study is to determine if using technological advancements to remotely, accurately, and securely monitor alcohol use with a newly developed breathalyzer is an effective treatment that is acceptable to participants. If validated, this treatment approach has the potential to facilitate the dissemination of an effective, evidence-based treatment for alcohol dependence to a broader population whose treatment needs are not currently being adequately met.

Enrollment

69 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • At least 18 years old
  • Provide written informed consent
  • Meet Diagnostic and Statistical Manual criteria for alcohol use disorder
  • Express a desire to cut down or quit drinking

Exclusion criteria

  • Pregnant or lactating
  • Meet Diagnostic and Statistical Manual criteria for other substance use disorder (except caffeine or nicotine)
  • Score 23 or greater on the Alcohol Withdrawal Symptom Checklist
  • Have immediate plans to move out of the area

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

69 participants in 2 patient groups

Contingent
Active Comparator group
Description:
The Contingent group will receive nearly immediate monetary payments over the internet each day they remotely provide negative breathalyzer samples, but will not receive the payments if they provide positive samples or fail to provide samples in a timely manner.
Treatment:
Behavioral: Contingency management: Contingent incentives
Noncontingent
Sham Comparator group
Description:
The Noncontingent group will receive payments each day they successfully provide samples independent of the alcohol content of those samples.
Treatment:
Behavioral: Contingency management: Noncontingent incentives

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems